Sign in
Optimizing inhibition of aldosterone: Use of spironolactone in chronic heart failure
Journal article   Peer reviewed

Optimizing inhibition of aldosterone: Use of spironolactone in chronic heart failure

Meredith Aull and Cynthia Sanoski
Formulary (Cleveland, Ohio), Vol.34(9), pp.752-763
09/01/1999

View Online

Abstract

Current research focuses on new treatment strategies that target the deleterious neurohormonal compensatory mechanisms that occur during heart failure. The clinical trails of spironolactone are discussed.
Beta blockers Clinical trials Diuretics Drug therapy Endocrine system Enzymes Heart failure Hemodynamics Kidneys Morbidity Mortality Nervous system Plasma Potassium Side effects Sodium

Details

Metrics

1 Record Views